The Roslin Institute
Roslin Logo

Dr Guraa Bergkvist

Highlighted Publications

Dual targeting of EGFR and ERBB2 pathways produces a synergistic effect on cancer cell proliferation and migration in vitro

Mark Edmund Gray, Seungmee Lee, Ashleigh L. McDowell, Matthew Erskine, Q.T.M. Loh, Olivia Grice, David Argyle, Guraa Bergkvist Veterinary and Comparative Oncology Vol: 15 Pages: 890-909 Sep 2017

Find out more...

Targeting multiple oncogenes simultaneously improves response to therapy and circumvents acquired resistance to single target tyrosine kinase inhibitors

Guraa Bergkvist, Mark Edmund Gray, Monoar Pallab, Seungmee Lee, Maybelle Qian Ting Loh, David Argyle, Donald Yool 24 May 2014

Find out more...

Expression of epidermal growth factor receptor (EGFR) and Ki67 in feline oral squamous cell carcinomas (FOSCC)

G. T. Bergkvist, D. J. Argyle, Linda Morrison, Neil Macintyre, A. Hayes, D. A. Yool Veterinary and Comparative Oncology Vol: 9 Pages: 106-117 Jun 2011

Find out more...

Studies on the inhibition of feline EGFR in squamous cell carcinoma: Enhancement of radiosensitivity and rescue of resistance to small molecule inhibitors

Guraa Bergkvist, David J. Argyle, Lisa Y. Pang, Rhona Muirhead, Donald A. Yool Cancer Biology & Therapy Vol: 11 Pages: 927-937 01 Jun 2011

Find out more...

Identification of tumour initiating cells in feline head and neck squamous cell carcinoma and evidence for gefitinib induced epithelial to mesenchymal transition.

Lisa Pang, Guraa Bergkvist, A Cervantes-Arias, Donald Yool, Rhona Muirhead, David Argyle The Veterinary Journal Vol: 193 Pages: 46-52 2012

Find out more...

Epidermal growth factor receptor as a therapeutic target in veterinary oncology

G.T. Bergkvist, D.A. Yool Veterinary and Comparative Oncology Vol: 9 Pages: 81-94 2011

Find out more...